Zydus Lifesciences Limited (BOM:532321)
India
· Delayed Price · Currency is INR 931.45
-3.75 (-0.40%)
At close: Dec 5, 2025
Zydus Lifesciences Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 4, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2020 - 2016 |
| Market Capitalization | 937,257 | 891,926 | 1,013,630 | 497,549 | 356,774 | 451,368 | Upgrade
|
| Market Cap Growth | -1.40% | -12.01% | 103.72% | 39.46% | -20.96% | 64.98% | Upgrade
|
| Enterprise Value | 990,812 | 892,181 | 1,022,435 | 525,557 | 387,118 | 504,363 | Upgrade
|
| Last Close Price | 931.45 | 875.67 | 991.39 | 480.25 | 338.29 | 425.19 | Upgrade
|
| PE Ratio | 19.05 | 19.71 | 26.26 | 25.38 | 7.95 | 21.16 | Upgrade
|
| PS Ratio | 3.83 | 3.84 | 5.19 | 2.89 | 2.36 | 3.13 | Upgrade
|
| PB Ratio | 3.34 | 3.38 | 4.59 | 2.53 | 1.87 | 3.02 | Upgrade
|
| P/TBV Ratio | 10.04 | 5.76 | 8.48 | 4.28 | 3.40 | 7.04 | Upgrade
|
| P/FCF Ratio | 36.93 | 17.61 | 44.27 | 30.01 | 39.56 | 18.50 | Upgrade
|
| P/OCF Ratio | 22.62 | 13.16 | 31.71 | 18.50 | 16.95 | 13.70 | Upgrade
|
| EV/Sales Ratio | 4.05 | 3.84 | 5.23 | 3.05 | 2.56 | 3.50 | Upgrade
|
| EV/EBITDA Ratio | 14.13 | 13.06 | 19.45 | 14.87 | 12.21 | 14.77 | Upgrade
|
| EV/EBIT Ratio | 16.42 | 14.97 | 22.53 | 18.42 | 15.65 | 18.44 | Upgrade
|
| EV/FCF Ratio | 39.04 | 17.62 | 44.65 | 31.70 | 42.92 | 20.67 | Upgrade
|
| Debt / Equity Ratio | 0.34 | 0.12 | 0.04 | 0.06 | 0.22 | 0.31 | Upgrade
|
| Debt / EBITDA Ratio | 1.39 | 0.47 | 0.16 | 0.34 | 1.33 | 1.35 | Upgrade
|
| Debt / FCF Ratio | 3.80 | 0.64 | 0.36 | 0.72 | 4.68 | 1.89 | Upgrade
|
| Asset Turnover | 0.63 | 0.70 | 0.71 | 0.64 | 0.59 | 0.61 | Upgrade
|
| Inventory Turnover | 1.64 | 1.77 | 1.87 | 1.81 | 1.64 | 1.64 | Upgrade
|
| Quick Ratio | 1.27 | 1.12 | 1.30 | 1.05 | 0.96 | 0.57 | Upgrade
|
| Current Ratio | 1.94 | 1.89 | 2.14 | 1.81 | 1.54 | 1.11 | Upgrade
|
| Return on Equity (ROE) | 19.25% | 19.28% | 18.90% | 10.82% | 13.96% | 16.91% | Upgrade
|
| Return on Assets (ROA) | 9.54% | 11.21% | 10.31% | 6.66% | 5.98% | 7.19% | Upgrade
|
| Return on Capital (ROIC) | 12.04% | 14.19% | 12.95% | 8.08% | 7.22% | 8.71% | Upgrade
|
| Return on Capital Employed (ROCE) | 16.00% | 21.20% | 19.00% | 14.10% | 12.40% | 17.10% | Upgrade
|
| Earnings Yield | 5.25% | 5.07% | 3.81% | 3.94% | 12.58% | 4.73% | Upgrade
|
| FCF Yield | 2.71% | 5.68% | 2.26% | 3.33% | 2.53% | 5.41% | Upgrade
|
| Dividend Yield | 1.18% | 1.26% | 0.30% | 1.25% | 0.74% | 0.82% | Upgrade
|
| Payout Ratio | 22.47% | 6.68% | 16.09% | 13.63% | 8.29% | 0.07% | Upgrade
|
| Buyback Yield / Dilution | 0.27% | 0.56% | 0.37% | 0.79% | - | - | Upgrade
|
| Total Shareholder Return | 1.44% | 1.82% | 0.67% | 2.04% | 0.74% | 0.82% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.